Evidence map›Paper›PMID 25636321›Full record

ReviewEukaryotic cell2015

Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets.

Shuyuan Liu, Yinglong Hou, Weiguo Liu, Chunyan Lu, Weixin Wang, Shujuan Sun

Open access · diamondAbstract readReview
In one paragraph

Review in Eukaryotic cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 1 synthesis or guideline pooled it, 176 citations in OpenAlex.

  1. Pooled it
  2. Veh1 modulates CaaBIOTECH · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Roles of Different Signaling Pathways inJournal of fungi (Basel, Switzerland) · 2024
    Review
  16. Review
  17. Article
  18. Accelerating the understanding ofCurrent research in microbial sciences · 2024
    Review
  19. Candidiasis in breast cancer: Tumor progression or not?Iranian journal of basic medical sciences · 2024
    Review
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shuyuan LiuSchool of Pharmaceutical Sciences, Shandong University, Jinan, Shandong Province, People's Republic of China.
Yinglong HouDepartment of Cardiology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong Province, People's Republic of China.
Weiguo LiuDepartment of Pharmacy, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong Province, People's Republic of China.
Chunyan LuDepartment of Pharmacy, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong Province, People's Republic of China.
Weixin WangDepartment of Pharmacy, Shandong Provincial Taishan Hospital, Taian, Shandong Province, People's Republic of China.
Shujuan SunDepartment of Pharmacy, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong Province, People's Republic of China sunshujuan888@163.com.
Shandong University · CNShandong Provincial QianFoShan Hospital · CNAffiliated Hospital of Taishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the emergence of fungal resistance has become frequent, partly due to the widespread clinical use of fluconazole, which is minimally toxic and effective in the prevention and treatment of Candida albicans infections. The limited selection of antifungal drugs for clinical fungal infection therapy has prompted us to search for new antifungal drug targets. Calcium, which acts as the second messenger in both mammals and fungi, plays a direct role in controlling the expression patterns of its signaling systems and has important roles in cell survival. In addition, calcium and some of the components, mainly calcineurin, in the fungal calcium signaling pathway mediate fungal resistance to antifungal drugs. Therefore, an overview of the components of the fungal calcium-calcineurin signaling network and their potential roles as antifungal targets is urgently needed. The calcium-calcineurin signaling pathway consists of various channels, transporters, pumps, and other proteins or enzymes. Many transcriptional profiles have indicated that mutant strains that lack some of these components are sensitized to fluconazole or other antifungal drugs. In addition, many researchers have identified efficient compounds that exhibit antifungal activity by themselves or in combination with antifungal drugs by targeting some of the components in the fungal calcium-calcineurin signaling pathway. This targeting disrupts Ca(2+) homeostasis, which suggests that this pathway contains potential targets for the development of new antifungal drugs.

Indexed as

Calcium SignalingDrug Resistance, FungalAntifungal AgentsCalcineurinCalciumCandida albicansCandidiasisCell MembraneFluconazoleGene Expression Regulation, FungalMicrobial Sensitivity TestsSaccharomyces cerevisiaeAntifungal AgentsCalcineurinCalciumFluconazole

Identifiers

PMID25636321
PMCPMC4385803
OpenAlexW2117365095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.